Description

1H-Indazole-1-Ethanamine,3-Ethyl-4,5,6,7-Tetrahydro-7,7-Dimethyl-(9Ci) is a high-purity, advanced pharmaceutical intermediate belonging to the indazole class of heterocyclic compounds. Its value lies in its role as a critical building block for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. This compound is essential for research and development chemists, process chemists, and manufacturers in the pharmaceutical and biotechnology industries who are developing next-generation drug candidates.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates targeting central nervous system (CNS) disorders, oncology, and inflammation.
• Chemical Research & Development: Serves as a versatile scaffold for medicinal chemistry programs, enabling the exploration of new structure-activity relationships (SAR).
• Process Chemistry & Scale-Up: Used in the development and optimization of robust, scalable synthetic routes for potential API manufacturing under cGMP conditions.
• Bioconjugation & Probe Development: The amine functionality allows for derivatization, making it suitable for creating labeled compounds for biochemical assays and diagnostic research.
• Agrochemical Research: Potential application as an intermediate in the development of new crop protection agents with novel modes of action.
• Material Science: Exploration as a monomer or additive for creating specialty polymers with unique thermal or optical properties.

Basic Information

Product Name	1H-Indazole-1-Ethanamine,3-Ethyl-4,5,6,7-Tetrahydro-7,7-Dimethyl-(9Ci)
CAS No.	561300-08-1
Molecular Formula	C13H23N3
Molecular Weight	221.34 g/mol
Synonyms	3-Ethyl-4,5,6,7-tetrahydro-7,7-dimethyl-1H-indazole-1-ethanamine; 1H-Indazole-1-ethanamine, 3-ethyl-4,5,6,7-tetrahydro-7,7-dimethyl- (9CI); 3-Ethyl-7,7-dimethyl-4,5,6,7-tetrahydro-1H-indazole-1-ethanamine; 1-(2-Aminoethyl)-3-ethyl-7,7-dimethyl-4,5,6,7-tetrahydro-1H-indazole; 561300-08-1
EINECS	Contact for details

Quality Control

Our 1H-Indazole-1-Ethanamine,3-Ethyl-4,5,6,7-Tetrahydro-7,7-Dimethyl-(9Ci) is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our commitment to quality supports compliance with relevant guidelines for advanced intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants or an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.